| Plasma renin activity predicts blood pressure responses to beta-blocker and thiazide diuretic as monotherapy and add-on therapy for hypertension. | |
| | |
MedLine Citation:
|
PMID: 20725057 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Age and race categories or renin profiling have been recommended to predict blood pressure responses to monotherapy with a beta-blocker or thiazide diuretic. Whether these or other characteristics predict blood pressure responses when the drugs are administered as add-on therapy is uncertain. METHODS: We evaluated predictors of blood pressure response in 363 men and women < or =65 years of age with primary hypertension (152 blacks, 211 whites), 86 of whom (24%) were untreated and 277 of whom (76%) were withdrawn from previous antihypertensive drugs before randomization to either atenolol followed by addition of hydrochlorothiazide (N = 180) or hydrochlorothiazide followed by addition of atenolol (N = 183). Responses were determined by home blood pressure averages before and after each drug administration. Race, age, plasma renin activity, and other characteristics including pretreatment blood pressure levels were incorporated into linear regression models to quantify their contributions to prediction of blood pressure responses. RESULTS: Plasma renin activity and pretreatment blood pressure level consistently contributed to prediction of systolic and diastolic responses to each drug administered as mono- and as add-on therapy. Higher plasma renin activity was consistently associated with greater blood pressure responses to atenolol and lesser responses to hydrochlorothiazide. The predictive effects of plasma renin activity were statistically independent of race, age, and other characteristics. CONCLUSIONS: Plasma renin activity and pretreatment blood pressure level predict blood pressure responses to atenolol and hydrochlorothiazide administered as mono- and as add-on therapy in men and women < or =65 years of age. |
| | |
Authors:
|
Stephen T Turner; Gary L Schwartz; Arlene B Chapman; Amber L Beitelshees; John G Gums; Rhonda M Cooper-DeHoff; Eric Boerwinkle; Julie A Johnson; Kent R Bailey |
Related Documents
:
|
2186637 - Measurement of renin secretion in single perfused rabbit glomeruli. 2444797 - Catecholamines, renin-angiotensin-aldosterone, and cardiovascular response during exerc... 12964647 - Role of kidney in hypertension. 8596377 - 15-year follow-up of renin and blood pressure in reflux nephropathy. 17677917 - Coherent anti-stokes raman spectroscopy of highly compressed solid deuterium at 300 k: ... 21645517 - Bi-modal dose-dependent cardiac response to tetrahydrobiopterin in pressure-overload in... |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. Date: 2010-08-19 |
Journal Detail:
|
Title: American journal of hypertension Volume: 23 ISSN: 1941-7225 ISO Abbreviation: Am. J. Hypertens. Publication Date: 2010 Sep |
Date Detail:
|
Created Date: 2010-08-24 Completed Date: 2010-12-07 Revised Date: 2013-05-28 |
Medline Journal Info:
|
Nlm Unique ID: 8803676 Medline TA: Am J Hypertens Country: United States |
Other Details:
|
Languages: eng Pagination: 1014-22 Citation Subset: IM |
Affiliation:
|
Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA. htndoc@mayo.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adrenergic beta-Antagonists
/
therapeutic use* Alcohol Drinking / adverse effects, epidemiology Antihypertensive Agents / therapeutic use* Blood Pressure / drug effects* Body Mass Index Drug Therapy, Combination Female Humans Hypertension / blood, drug therapy* Male Middle Aged Randomized Controlled Trials as Topic Renin / blood* Sodium Chloride Symporter Inhibitors / therapeutic use* Treatment Outcome |
| Grant Support | |
ID/Acronym/Agency:
|
K23 HL091120/HL/NHLBI NIH HHS; K23-HL091120/HL/NHLBI NIH HHS; M01 RR000585-332081/RR/NCRR NIH HHS; M01 RR000585-342081/RR/NCRR NIH HHS; M01-RR 00585/RR/NCRR NIH HHS; M01‑RR 00039/RR/NCRR NIH HHS; U01 GM074492/GM/NIGMS NIH HHS; U01 GM074492-07/GM/NIGMS NIH HHS; U01-GM074492/GM/NIGMS NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic beta-Antagonists; 0/Antihypertensive Agents; 0/Sodium Chloride Symporter Inhibitors; EC 3.4.23.15/Renin |
| Comments/Corrections | |
Comment In:
|
Am J Hypertens. 2010 Sep;23(9):926-8
[PMID:
20733564
]
Am J Hypertens. 2010 Sep;23(9):929-30 [PMID: 20733565 ] |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Ethnic differences in blood pressure response to first and second-line antihypertensive therapies in...
Next Document: Preventing obesity during infancy: a pilot study.